arrow
E

Elise F. Nassif

sarcoma medical oncology
H指数:14
被引数:805

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Case Report: Complete response to the concurrent neoadjuvant radiation therapy and pembrolizumab in a locally recurrent; chemotherapy-refractory undifferentiated pleomorphic sarcoma of bone

病例报告:局部复发的、对化疗耐药的骨未分化多形性肉瘤对同时进行的术前放疗和帕博利珠单抗治疗完全缓解

2026-02-160
OAAI
Dedifferentiated liposarcomas treated with immune checkpoint blockade: the MD Anderson experience

分化型脂肪肉瘤接受免疫检查点阻断治疗:MD Anderson经验

2025-04-300
OA
Can proteomics predict metastatic relapse in leiomyosarcoma (LMS)? Development of an 8 protein signature in a >350 sample study including a validation cohort

蛋白质组学能否预测子宫平滑肌肉瘤(LMS)的转移复发?一项包含验证队列的>350样本研究中的8蛋白标志物的开发

2024-09-010
PRE
ASO Visual Abstract: High Community-Level Social Vulnerability is Associated with Worse Recurrence-Free Survival Following Resection of Extremity and Truncal Soft-Tissue Sarcoma
2024-03-280
PRE
Peripheral CD38+effector memory (EM) T cells are dynamic biomarkers of response to neoadjuvant immune checkpoint blockade (NeoICB) in patients (pts) with resectable dedifferentiated liposarcoma (DDLPS) and undifferentiated pleomorphic sarcoma (UPS)
2024-03-220
PRE
Spatial profiling reveals unique immune-transcriptomic features of tertiary lymphoid structures in melanoma
2024-03-220
PRE
High Community-Level Social Vulnerability is Associated with Worse Recurrence-Free Survival (RFS) After Resection of Extremity and Truncal Soft Tissue Sarcoma
2024-02-232
PRE
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma
2024-02-1310
PRE